BSE Live
Apr 02, 16:01Prev. Close
58.92
Open Price
55.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Aspira Pathlab & Diagnostics (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 2.01 | -2.60 | -0.09 | 4.33 | 1.45 | |
| Diluted EPS (Rs.) | 2.01 | -2.60 | -0.09 | 4.33 | 1.45 | |
| Cash EPS (Rs.) | 3.46 | -1.10 | 1.45 | 5.92 | 2.75 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 7.08 | 5.07 | 7.60 | 7.64 | 3.29 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 7.08 | 5.07 | 7.60 | 7.64 | 3.29 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 21.37 | 12.83 | 14.05 | 18.99 | 14.77 | |
| PBDIT/Share (Rs.) | 3.80 | -0.74 | 1.86 | 6.28 | 3.61 | |
| PBIT/Share (Rs.) | 2.35 | -2.24 | 0.32 | 4.69 | 2.21 | |
| PBT/Share (Rs.) | 2.01 | -2.60 | -0.09 | 4.33 | 1.34 | |
| Net Profit/Share (Rs.) | 2.01 | -2.60 | -0.09 | 4.33 | 1.34 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 17.79 | -5.79 | 13.24 | 33.09 | 24.44 | |
| PBIT Margin (%) | 11.00 | -17.45 | 2.27 | 24.72 | 14.94 | |
| PBT Margin (%) | 9.42 | -20.23 | -0.61 | 22.81 | 9.08 | |
| Net Profit Margin (%) | 9.42 | -20.23 | -0.61 | 22.81 | 9.08 | |
| Return on Networth / Equity (%) | 28.44 | -51.25 | -1.13 | 56.73 | 40.80 | |
| Return on Capital Employed (%) | 15.98 | -18.23 | 2.08 | 29.56 | 23.27 | |
| Return on Assets (%) | 11.83 | -18.16 | -0.51 | 24.58 | 11.72 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.12 | 0.11 | 0.37 | |
| Asset Turnover Ratio (%) | 1.37 | 0.82 | 0.82 | 1.31 | 1.16 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.26 | 2.10 | 3.70 | 3.99 | 1.93 | |
| Quick Ratio (X) | 2.05 | 1.89 | 3.44 | 3.77 | 1.75 | |
| Inventory Turnover Ratio (X) | 45.90 | 31.21 | 6.22 | 8.14 | 8.19 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 86.79 | 31.60 | 27.28 | 65.91 | 29.40 | |
| EV/Net Operating Revenue (X) | 3.95 | 2.39 | 1.89 | 3.37 | 1.93 | |
| EV/EBITDA (X) | 22.18 | -41.27 | 14.25 | 10.19 | 7.91 | |
| MarketCap/Net Operating Revenue (X) | 3.99 | 2.42 | 1.98 | 3.41 | 1.93 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 12.04 | 6.12 | 3.67 | 8.49 | 8.67 | |
| Price/Net Operating Revenue | 3.99 | 2.42 | 1.98 | 3.41 | 1.93 | |
| Earnings Yield | 0.02 | -0.08 | 0.00 | 0.07 | 0.05 |
25.02.2026
Aspira Pathlab Standalone December 2025 Net Sales at Rs 5.12 crore, down 5.34% Y-o-Y
13.08.2025
Aspira Pathlab Consolidated June 2025 Net Sales at Rs 5.25 crore, up 13.17% Y-o-Y
19.05.2025
Aspira Pathlab Standalone March 2025 Net Sales at Rs 5.78 crore, up 51.31% Y-o-Y
10.02.2025
Aspira Pathlab Standalone December 2024 Net Sales at Rs 5.41 crore, up 56.21% Y-o-Y